Andrea van Elsas is a partner at Third Rock Ventures. He has experience in oncology and immunology therapeutics and has held scientific leadership roles.
What Andrea can write
Career
- BioNovion
- Aduro Biotech · chief scientific officer
- Third Rock Ventures · venture partnerNow
- Abata Therapeutics · founding CSO
- Third Rock Ventures · partnerNow
- Abata Therapeutics · interim chief scientific officer
Investments named in public bios
Focus
Also at Third Rock Ventures
Partners like Andrea
At firms with a similar stage, sector and check size.
Alert me when Third Rock Ventures is active
One email when Andrea's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Andrea van Elsas, Ph.D.?
Andrea van Elsas is a partner at Third Rock Ventures. He has experience in oncology and immunology therapeutics and has held scientific leadership roles.
How much does Andrea van Elsas, Ph.D. invest?
Third Rock Ventures has not reported a check size. It invests at seed, series a.
How do I pitch Andrea van Elsas, Ph.D.?
Email [email protected], the firm's inbox for founders, and name Andrea in the subject. A warm intro from a founder Third Rock Ventures backed works better.
What did Andrea van Elsas, Ph.D. do before Third Rock Ventures?
BioNovion; chief scientific officer at Aduro Biotech; founding CSO at Abata Therapeutics; interim chief scientific officer at Abata Therapeutics.
Last updated 2026-10-15. Is this you? Ask for a correction.